Biotelemetry Inc (BEAT) 19.19 $BEAT
BioTelemetry, Inc. to Release Second Quarter 2016 Earnings Results on August 2, 2016
GlobeNewswire - Tue Jul 26, 3:15PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2016 earnings on Tuesday, August 2, 2016 at 4:00 PM Eastern Time.
BEAT: 19.19 (+0.17)
BioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT(TM) Patch
GlobeNewswire - Tue Jul 26, 7:30AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that it has received U.S. Food and Drug Administration ("FDA"
510(k) clearance of its next generation Mobile Cardiac Outpatient Telemetry(TM) device, the MCOT(TM) Patch. The MCOT(TM) Patch is a four-lead, two-channel system which provides the same best in class technology as the current MCOT(TM), in a more convenient form factor. The MCOT(TM) devices, through the use of a proprietary algorithm, offer the most accurate remote arrhythmia detection available on the market.
BEAT: 19.19 (+0.17)
MB Financial to Join S&P MidCap 400; BioTelemetry and Raven Industries to Join S&P SmallCap 600
PR Newswire - Mon Jul 25, 5:41PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices after the close of trading on Friday, July 29:
SPGI: 121.22 (-0.98), WIBC: 10.74 (-0.20), BEAT: 19.19 (+0.17), FNFG: 10.18 (-0.02), MBFI: 37.96 (-0.43), RAVN: 20.96 (+0.20), KEY: 11.48 (-0.22), BBCN: 15.37 (-0.21)
MEDNAX Acquires Pediatric Cardiology Practice in Virginia
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 7:13AM CDT
MEDNAX, Inc (MD) recently announced acquisition of Pediatric Cardiology Associates (PC), which is a private physician group practice in Fairfax, VA.
HYH: 34.07 (-0.52), BEAT: 19.19 (+0.17), AHS: 43.31 (+1.01), MD: 68.99 (+0.08)
Wright Medical to Sell Large Joints Business to Corin Holdings
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 9:13AM CDT
Wright Medical Group N.V. (WMGI) is set to divest its large joint business to Corin Holdings.
ABMD: 119.50 (+1.53), WMGI: 21.64 (-0.29), BEAT: 19.19 (+0.17), MLAB: 114.10 (-1.53)
Strength Seen in Biotelemetry (BEAT): Stock Soars 5.8%
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:30AM CDT
Biotelemetry, Inc. (BEAT) shares rose almost 6% in the last trading session.
BEAT: 19.19 (+0.17), AHS: 43.31 (+1.01)
The Ensign Group (ENSG) Acquires Riverbend, Shares Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:52PM CDT
The Ensign Group Inc. (ENSG) recently acquired Kansas City-based Riverbend Post Acute Rehabilitation.
ENSG: 21.49 (-0.01), ABMD: 119.50 (+1.53), ABCO: 42.00 (+0.24), BEAT: 19.19 (+0.17)
Cooper Companies Strong on Portfolio Expansion Plans
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:38AM CDT
The Cooper Companies Inc. (COO) is firing on all cylinders, buoyed by its expanding product portfolio and consistent earnings results.
BSX: 24.43 (+0.15), JNJ: 125.40 (+0.17), BEAT: 19.19 (+0.17), COO: 182.61 (+0.14)
42.6% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Wed Jun 15, 12:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 4 months, CardioNet has returned 42.64% as of today's recent price of $15.99.
BEAT: 19.19 (+0.17)
HealthEquity Q1 Earnings Top, Revenues Rise Y/Y; View Up
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:35AM CDT
Shares of HealthEquity Inc (HQY) increased almost 4% in after-hours following impressive first-quarter fiscal 2017 results.
AIRM: 32.70 (-0.59), HQY: 29.23 (-0.29), BEAT: 19.19 (+0.17), AHS: 43.31 (+1.01)
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
ETM: 13.93 (-0.68), AG: 17.88 (+0.54), BEAT: 19.19 (+0.17), BGSF: 21.01 (-0.05), ORRF: 19.44 (+0.10)
Shares of BEAT Up 52.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:15AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 52.19% as of today's recent price of $17.06.
BEAT: 19.19 (+0.17)
5 Breakout Stocks Under $20
Zacks Equity Research - Zacks Investment Research - Fri May 27, 11:15AM CDT
The breakout strategy is probably the most commonly used one by active investors.
ETM: 13.93 (-0.68), AG: 17.88 (+0.54), BEAT: 19.19 (+0.17), BGSF: 21.01 (-0.05), ORRF: 19.44 (+0.10)
Medical Service Stocks Should be on your Buying Radar
Zacks Premium Research - Zacks Investment Research - Wed May 25, 3:47PM CDT
Investing in this industry now could pay off for you over the short term.
HQY: 29.23 (-0.29), BEAT: 19.19 (+0.17), AHS: 43.31 (+1.01)
Uptrend Call Working As CardioNet Stock Rises 36.5% (BEAT)
Comtex SmarTrend(R) - Mon May 23, 12:56PM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 36.53% as of today's recent price of $15.31.
BEAT: 19.19 (+0.17)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 19.19 (+0.17), BRKR: 24.81 (-0.11), PKI: 56.69 (-0.23), WAT: 159.58 (+0.65)
BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.
GlobeNewswire - Wed May 11, 8:25AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions. The acquisition comes after the successful completion of the all cash tender offer for all outstanding common and preferred shares of VirtualScopics. The total purchase consideration was approximately $15.0 million, net of cash and debt acquired.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)
BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc.
GlobeNewswire - Tue May 10, 7:05AM CDT
BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the tender offer of its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror", to purchase all outstanding common and preferred shares of VirtualScopics, Inc. ("VirtualScopics"; (NASDAQ:VSCP) at an offer price of $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock, expired as scheduled at 5:00 p.m., New York City time, on Monday, May 9, 2016, and was not extended.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)
BioTelemetry, Inc. to Release Second Quarter 2016 Earnings Results on August 2, 2016
GlobeNewswire - Tue Jul 26, 3:15PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2016 earnings on Tuesday, August 2, 2016 at 4:00 PM Eastern Time.
BEAT: 19.19 (+0.17)
BioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT(TM) Patch
GlobeNewswire - Tue Jul 26, 7:30AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that it has received U.S. Food and Drug Administration ("FDA"
510(k) clearance of its next generation Mobile Cardiac Outpatient Telemetry(TM) device, the MCOT(TM) Patch. The MCOT(TM) Patch is a four-lead, two-channel system which provides the same best in class technology as the current MCOT(TM), in a more convenient form factor. The MCOT(TM) devices, through the use of a proprietary algorithm, offer the most accurate remote arrhythmia detection available on the market. BEAT: 19.19 (+0.17)
MB Financial to Join S&P MidCap 400; BioTelemetry and Raven Industries to Join S&P SmallCap 600
PR Newswire - Mon Jul 25, 5:41PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices after the close of trading on Friday, July 29:
SPGI: 121.22 (-0.98), WIBC: 10.74 (-0.20), BEAT: 19.19 (+0.17), FNFG: 10.18 (-0.02), MBFI: 37.96 (-0.43), RAVN: 20.96 (+0.20), KEY: 11.48 (-0.22), BBCN: 15.37 (-0.21)
MEDNAX Acquires Pediatric Cardiology Practice in Virginia
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 7:13AM CDT
MEDNAX, Inc (MD) recently announced acquisition of Pediatric Cardiology Associates (PC), which is a private physician group practice in Fairfax, VA.
HYH: 34.07 (-0.52), BEAT: 19.19 (+0.17), AHS: 43.31 (+1.01), MD: 68.99 (+0.08)
Wright Medical to Sell Large Joints Business to Corin Holdings
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 9:13AM CDT
Wright Medical Group N.V. (WMGI) is set to divest its large joint business to Corin Holdings.
ABMD: 119.50 (+1.53), WMGI: 21.64 (-0.29), BEAT: 19.19 (+0.17), MLAB: 114.10 (-1.53)
Strength Seen in Biotelemetry (BEAT): Stock Soars 5.8%
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:30AM CDT
Biotelemetry, Inc. (BEAT) shares rose almost 6% in the last trading session.
BEAT: 19.19 (+0.17), AHS: 43.31 (+1.01)
The Ensign Group (ENSG) Acquires Riverbend, Shares Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:52PM CDT
The Ensign Group Inc. (ENSG) recently acquired Kansas City-based Riverbend Post Acute Rehabilitation.
ENSG: 21.49 (-0.01), ABMD: 119.50 (+1.53), ABCO: 42.00 (+0.24), BEAT: 19.19 (+0.17)
Cooper Companies Strong on Portfolio Expansion Plans
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:38AM CDT
The Cooper Companies Inc. (COO) is firing on all cylinders, buoyed by its expanding product portfolio and consistent earnings results.
BSX: 24.43 (+0.15), JNJ: 125.40 (+0.17), BEAT: 19.19 (+0.17), COO: 182.61 (+0.14)
42.6% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Wed Jun 15, 12:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 4 months, CardioNet has returned 42.64% as of today's recent price of $15.99.
BEAT: 19.19 (+0.17)
HealthEquity Q1 Earnings Top, Revenues Rise Y/Y; View Up
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:35AM CDT
Shares of HealthEquity Inc (HQY) increased almost 4% in after-hours following impressive first-quarter fiscal 2017 results.
AIRM: 32.70 (-0.59), HQY: 29.23 (-0.29), BEAT: 19.19 (+0.17), AHS: 43.31 (+1.01)
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
ETM: 13.93 (-0.68), AG: 17.88 (+0.54), BEAT: 19.19 (+0.17), BGSF: 21.01 (-0.05), ORRF: 19.44 (+0.10)
Shares of BEAT Up 52.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:15AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 52.19% as of today's recent price of $17.06.
BEAT: 19.19 (+0.17)
5 Breakout Stocks Under $20
Zacks Equity Research - Zacks Investment Research - Fri May 27, 11:15AM CDT
The breakout strategy is probably the most commonly used one by active investors.
ETM: 13.93 (-0.68), AG: 17.88 (+0.54), BEAT: 19.19 (+0.17), BGSF: 21.01 (-0.05), ORRF: 19.44 (+0.10)
Medical Service Stocks Should be on your Buying Radar
Zacks Premium Research - Zacks Investment Research - Wed May 25, 3:47PM CDT
Investing in this industry now could pay off for you over the short term.
HQY: 29.23 (-0.29), BEAT: 19.19 (+0.17), AHS: 43.31 (+1.01)
Uptrend Call Working As CardioNet Stock Rises 36.5% (BEAT)
Comtex SmarTrend(R) - Mon May 23, 12:56PM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 36.53% as of today's recent price of $15.31.
BEAT: 19.19 (+0.17)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 19.19 (+0.17), BRKR: 24.81 (-0.11), PKI: 56.69 (-0.23), WAT: 159.58 (+0.65)
BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.
GlobeNewswire - Wed May 11, 8:25AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions. The acquisition comes after the successful completion of the all cash tender offer for all outstanding common and preferred shares of VirtualScopics. The total purchase consideration was approximately $15.0 million, net of cash and debt acquired.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)
BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc.
GlobeNewswire - Tue May 10, 7:05AM CDT
BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the tender offer of its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror"
, to purchase all outstanding common and preferred shares of VirtualScopics, Inc. ("VirtualScopics"; (NASDAQ:VSCP) at an offer price of $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock, expired as scheduled at 5:00 p.m., New York City time, on Monday, May 9, 2016, and was not extended. VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)
